FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 2911192 · Received January 11, 2013

Report

Report Number
2124215-2012-16046
Event Type
Malfunction
Date Received
January 11, 2013
Date of Event
November 29, 2012
Report Date
November 29, 2012
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THROUGH A REMOTE MONITORING SYSTEM THAT THIS DEVICE DETECTED AN OUT OF RANGE SHOCK IMPEDANCE MEASUREMENT ON THE RIGHT VENTRICULAR (RV) LEAD. TESTING WAS PERFORMED AND ALL OTHER MEASUREMENTS WERE CONFIRMED TO BE APPROPRIATE. A CONTINUOUS MEASUREMENT OF THE SHOCK IMPEDANCE MEASUREMENTS WERE CARRIED OUT AND MEASUREMENTS WERE NORMAL. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
18693 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F103

Patients

Seq Age Sex Outcome Treatment
1 76 YR 4543| 4538| 4512| 0185| 4474| 4517| H175| H170| 0184